Kevin Waters sold $604k of PRCT
EVP, CFO at PROCEPT BioRobotics Corp. 15,085 shares at an average of $40.01, traded Dec 6, 2023, filed Dec 8, 2023.
Score components
- +22RoleCFO
- +19Trade size$604k at market
- +10Share of holdings soldSold 31% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-23-041166, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 6, 2023 | MOption exercise Common Stock10b5-1 | +4,360 | $4.52 | $20k | 37,883 | Dec 8, 2023 |
| Dec 7, 2023 | MOption exercise Common Stock10b5-1 | +3,837 | $4.52 | $17k | 41,720 | Dec 8, 2023 |
| Dec 8, 2023 | MOption exercise Common Stock10b5-1 | +6,888 | $4.52 | $31k | 48,608 | Dec 8, 2023 |
| Dec 6, 2023 | SOpen-market sale Common Stock10b5-1 | -4,360 | $40.02 | $174k | 44,248 | Dec 8, 2023 |
| Dec 7, 2023 | SOpen-market sale Common Stock10b5-1 | -3,837 | $40.00 | $153k | 40,411 | Dec 8, 2023 |
| Dec 8, 2023 | SOpen-market sale Common Stock10b5-1 | -6,888 | $40.02 | $276k | 33,523 | Dec 8, 2023 |
| Dec 6, 2023 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,360 | $0.00 | $0 | 203,357 | Dec 8, 2023 |
| Dec 7, 2023 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,837 | $0.00 | $0 | 199,520 | Dec 8, 2023 |
| Dec 8, 2023 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,888 | $0.00 | $0 | 192,632 | Dec 8, 2023 |
Related signals
Other insiders at PROCEPT BioRobotics Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $6,223 297 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $7,815 373 shares | -0% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $7,815 373 shares | -0% | |
| 59Moderate | PRCTbuy PROCEPT BioRobotics Corp | Larry L Wood President, CEO | $498k 23,900 shares | - | |
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,117 285 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $10k 358 shares | -1% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $10k 357 shares | -0% | |
| 23Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,559 304 shares | -0% | |
| 14Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $139k 5,363 shares | -5% | |
| 30Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $20k 706 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.